HCA Healthcare (NYSE:HCA) Given New $416.00 Price Target at Barclays

HCA Healthcare (NYSE:HCA - Free Report) had its price target upped by Barclays from $366.00 to $416.00 in a research report sent to investors on Monday,Benzinga reports. They currently have an overweight rating on the stock.

HCA has been the topic of a number of other reports. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Royal Bank of Canada reduced their target price on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Robert W. Baird reiterated a "neutral" rating and issued a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Guggenheim assumed coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Finally, Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and a consensus target price of $388.80.

HCA Healthcare Trading Up 0.3%

HCA traded up $1.07 during midday trading on Monday, reaching $383.23. 1,220,792 shares of the company's stock traded hands, compared to its average volume of 1,439,422. The firm has a fifty day moving average of $352.18 and a two-hundred day moving average of $330.35. The stock has a market capitalization of $92.19 billion, a price-to-earnings ratio of 17.44, a P/E/G ratio of 1.10 and a beta of 1.46. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the company earned $5.36 EPS. On average, equities analysts anticipate that HCA Healthcare will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's payout ratio is presently 12.81%.

Insider Buying and Selling at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by corporate insiders.

Institutional Trading of HCA Healthcare

Several hedge funds have recently made changes to their positions in HCA. Avantax Advisory Services Inc. boosted its position in shares of HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after purchasing an additional 32 shares during the period. Glenview Trust co boosted its holdings in HCA Healthcare by 2.3% during the first quarter. Glenview Trust co now owns 1,451 shares of the company's stock worth $501,000 after buying an additional 32 shares in the last quarter. Horizon Investments LLC raised its position in HCA Healthcare by 1.1% during the first quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock worth $1,097,000 after acquiring an additional 33 shares during the last quarter. Congress Wealth Management LLC DE raised its position in shares of HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after buying an additional 34 shares during the last quarter. Finally, Evergreen Private Wealth LLC raised its position in shares of HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after buying an additional 35 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.